A federal appeals court in New Orleans is expected to weigh in on whether a commonly used pill, mifepristone, should remain widely available. Here is what’s at stake.
The order halts lower court rulings that would have restricted the drug as an appeal moves forward in a case with profound implications for abortion access and the F.D.A.’s regulatory authority.
One federal judge said the F.D.A.’s approval of the drug mifepristone was invalid, while another federal judge ordered the agency to keep the pill available. The legal fallout is just beginning.
One invalidated the F.D.A.’s approval of the abortion pill mifepristone. The other ordered the F.D.A. to do nothing to restrict the pill’s availability.